Arthritis drug increases survival chances for severe Covid-19 patients: study

Stands in contrast with another study published that found thattocilizumab did not significantly improve clinical status or mortality rate at 28 days
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *